Ortho Clinical Diagnostics to showcase seven posters of vital tests, six products at AACC meeting

Ortho Clinical Diagnostics today announced it will present seven scientific posters on its assays and display six products at its booth at the 2016 American Association for Clinical Chemistry (AACC) annual meeting. The conference will be held July 31 - August 4 in Philadelphia's Pennsylvania Convention Center. Ortho's posters will address a range of important tests, both marketed and in-development for clinical labs, including HIV, Chagas disease and thyroid function.

"Ortho is focused on expanding its assay portfolio and creating laboratory technology that features full testing automation and optimizes the power of informatics," said Karen Davis-Fleischer, vice president and head of business fields - Clinical Labs Menu, for Ortho. "We look forward to sharing information on the development of our assays and showcasing our most recent innovations, which help enable our customers to reduce turnaround times and broaden their testing menus."

The posters Ortho will display at the conference are:

Evaluation of the Performance of the VITROS® Immunodiagnostic Products HIV Combo Assay at Two European Trial Sites
Poster Session: August 3 from 9:30 a.m. to 5 p.m.; Infectious Disease (13)
Author Presentation: 12:30 - 1:30 p.m.
Presenter: Paul Contestable, principal scientist, Ortho Clinical Diagnostics

Development of a High Sensitivity Prototype Assay for Thyroid Stimulating Hormone
Poster Session: August 2 from 9:30 a.m. to 5 p.m.; Endocrinology/Hormones (04)
Author Presentation: 12:30 - 1:30 p.m.
Presenter: Phil Hosimer, senior principal scientist, Ortho Clinical Diagnostics

Development of an Enhanced Chemiluminescent C-peptide Assay
Poster Session: August 2 from 9:30 a.m. to 5 p.m.; Endocrinology/Hormones (04)
Author Presentation: 12:30 - 1:30 p.m.
Presenter: Holly Groth, staff scientist, Ortho Clinical Diagnostics

Standardization and Harmonization of Ortho Clinical Diagnostics Thyroid Function Tests
Poster Session: August 2 from 9:30 a.m. to 5 p.m.; Endocrinology/Hormones (04)
Author Presentation: 12:30 - 1:30 p.m.
Presenter: Chris Thomas, principal scientist, Ortho Clinical Diagnostics

Evaluation of the Performance of the New VITROS® LDHI Assay Slide
Poster Session: August 3 from 9:30 a.m. to 5 p.m.; Proteins/Enzymes (19)
Author Presentation: 12:30 - 1:30 p.m.
Presenter: Scott Hewitson, senior scientist, Ortho Clinical Diagnostics

Performance of a Prototype T. cruzi Assay for the Detection of Chagas Disease
Poster Session: August 3 from 9:30 a.m. to 5 p.m.; Infectious Disease (13)
Author Presentation: 12:30 - 1:30 p.m.
Presenter: Sue Danielson, research fellow, Ortho Clinical Diagnostics

Comparative Study of Six Sigma Assay Performance on VITROS® Systems
Poster Session: August 3 from 9:30 a.m. to 5 p.m.; Management (15)
Author Presentation: 12:30 - 1:30 p.m.
Presenter: Andy Kirsch, manager, systems support and field triage, Ortho Clinical Diagnostics

Products on display in Ortho's booth (No. 1100) at AACC will include Ortho's flagship Integrated Clinical Chemistry and Immunodiagnostic Systems and the Nephrocheck® Test. Ortho will also highlight the company's transfusion medicine instrument, The ORTHO VISION® MAX.

Visitors to the booth will also be able to witness how the enGen™ Laboratory Automation system, used in combination with the VITROS® Systems and informatics solutions, helps clinical labs automate, streamline and standardize workflow. Auto-verification improves security, increases walk-away time and diminishes costs, allowing lab professionals to more efficiently manage testing.

"Every product and service that Ortho offers reflects our commitment to reimagining what's possible in labs today," said Michael Iskra, president, North America Commercial Operations. "Lab professionals are challenged to do more with limited resources and increasing demand. We're redefining possibilities, offering comprehensive, fully integrated laboratory solutions that enhance the total value of instrument ownership."

The company will also host an invitation-only customer event at the Franklin Institute on Tuesday, August 2, from 5 p.m. to 9:30 p.m., featuring a session on empowering lab directors to work effectively with C-level hospital executives, as well as a lecture on the changing landscape of heart failure biomarkers.

Another highlight of Ortho's presence at the meeting will be an in-booth virtual reality lab visualization station. Using the latest 3D technology, visitors will work with our design team to custom build their own dream laboratories. They'll then tour the creations via virtual reality, learning how proprietary Ortho technology allows labs to grow and change as their needs do. The booth will also feature a theatre with a rotating roster of key opinion leader presentations and a lab informatics station.

Source:

2016 AACC Annual Meeting Press Program

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Measuring the binding of SARS-CoV-2 antibodies to the COVID spike protein using SPR